Dr. David A. Diloreto Jr., MD

Dr. Diloreto practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Diloreto's NPI, 1144253154, was assigned on July 10, 2006. Dr. Diloreto graduated from University of Rochester School of Medicine and Dentistry in 1997. Dr. Diloreto holds New York license 227128.

Dr. Diloreto's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Diloreto's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Diloreto to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diloreto practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Diloreto's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Diloreto is licensed in New York.

CMS data shows 983 Medicare services from Dr. Diloreto across 7 procedure codes in 2024, for 221 Medicare patients. Medicare paid $94,029 for them.

CMS counts 221 Medicare patients who saw Dr. Diloreto in 2024. The largest group is 65 to 74, with 86 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Diloreto's median patient age at 75, with 50% women.

In 2024, Dr. Diloreto wrote 233 Medicare Part D claims for 63 patients. 68% of them were for generic drugs. CMS names the drug for 181 of them, across 7 drugs with 11 or more claims each, at $6,265 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Diloreto for performance year 2024, reported as part of a group. Dr. Diloreto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Diloreto, published from 2011 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Fluorescein Angiography, Fundus Oculi and Photoreceptor Cells. Dr. Diloreto has published most often in Retin Cases Brief Rep. Dr. Diloreto's most frequent co-authors are Vamsi Krishna Gullapalli, MD, PhD, Rajeev S. Ramchandran, MD and Suveera Dang, MD.

CMS Open Payments shows 14 general payments to Dr. Diloreto from 7 drug and device companies from 2018 to 2024. Grants make up the largest share, 84% of the total. Bausch & Lomb Americas Inc. paid the most, $7,750.

Dr. Diloreto graduated from University of Rochester School of Medicine and Dentistry in 1997.